As expected from the literature and according to their CIN profile [25] non-HM tumors had higher mutation rate in APC (84%), TP53 (69%) and KRAS (41%) compared to HM tumors (Table 2). This evidence concerns the gene KRAS and cervical squamous intraepithelial neoplasia.